CLINICAL_TRIALS
trial_result
· 2024-05-20
Clinical Trial Update: The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study
Summary
The INVADER PMCF post-market study for the INVADER PTCA device has completed follow-up, with data collection in patients with coronary artery disease and relate…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alvimedica | Conditions: Coronary Artery Disease, Coronary Disease | Status: COMPLETED